Brinker Capital Investments’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
76,532
-1,877
| -2% | -$38.3K | 0.01% | 931 |
|
|
2025
Q1 | $1.57M | Buy |
78,409
+10,093
| +15% | +$202K | 0.02% | 836 |
|
|
2024
Q4 | $1.82M | Sell |
68,316
-4,089
| -6% | -$109K | 0.02% | 751 |
|
|
2024
Q3 | $2.06M | Buy |
72,405
+10,324
| +17% | +$294K | 0.02% | 673 |
|
|
2024
Q2 | $1.35M | Sell |
62,081
-5,156
| -8% | -$112K | 0.01% | 836 |
|
|
2024
Q1 | $1.49M | Sell |
67,237
-2,496
| -4% | -$55.3K | 0.02% | 798 |
|
|
2023
Q4 | $1.53M | Sell |
69,733
-4,294
| -6% | -$93.9K | 0.02% | 759 |
|
|
2023
Q3 | $1.25M | Sell |
74,027
-3,523
| -5% | -$59.5K | 0.02% | 823 |
|
|
2023
Q2 | $1.06M | Buy |
77,550
+47,885
| +161% | +$657K | 0.01% | 927 |
|
|
2023
Q1 | $674K | Sell |
29,665
-3,159
| -10% | -$71.8K | 0.01% | 1031 |
|
|
2022
Q4 | $773K | Sell |
32,824
-3,636
| -10% | -$85.6K | 0.02% | 824 |
|
|
2022
Q3 | $951K | Buy |
36,460
+7,882
| +28% | +$206K | 0.02% | 731 |
|
|
2022
Q2 | $627K | Sell |
28,578
-6,683
| -19% | -$147K | 0.01% | 896 |
|
|
2022
Q1 | $1.58M | Buy |
35,261
+7,541
| +27% | +$338K | 0.02% | 623 |
|
|
2021
Q4 | $1.19M | Sell |
27,720
-22,441
| -45% | -$962K | 0.02% | 751 |
|
|
2021
Q3 | $3.68M | Hold |
50,161
| – | – | 0.06% | 347 |
|
|
2021
Q2 | $3.68M | Buy |
+50,161
| New | +$3.68M | 0.05% | 396 |
|